Stockreport

How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice [Yahoo! Finance]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF The updated analyst work on OptimizeRx centers on a sharp reset in the stock's fair value estimate, with the price target revised from US$24.33 to US$14.50, a cut of ro [Read more]